During this session, Brandon Bogdalek will interview three (3) panelists from in the drug delivery and pharmaceutical industry. The panelists will discuss important factors to consider when evaluating off-the-shelf (OTS) drug delivery platform vs. developing a novel solution. Key topics will include cost and pricing impacts, timeline to commercialization, as well as R&D, human factors, and user needs considerations. Panelists will share their perspectives with respect to choosing OTS solutions or building a novel drug delivery platform.
Key Takeaways
-
- Important tradeoffs when considering an OTS drug delivery platform vs. novel development.
- Best practices for novel drug delivery design and development
- Important R&D considerations including timeline to commercialization, human factors, user needs, and more
Panelists
Tuesday, July 11, 2023 @ 1-2pm EDT (10-11am PDT / 12-1pm CDT)